VUMC News and Communications Archive — Page 165 of 391
-
October 31, 2017
Piedmont Natural Gas and Monroe Carell Jr. Children’s Hospital at Vanderbilt continue partnership for 64th Annual Nashville Christmas Parade presented by Tootsie’s
Officials from Piedmont Natural Gas and Monroe Carell Jr. Children’s Hospital at Vanderbilt, joined by Nashville Mayor Megan Barry, announced today that retired Nashville Predators Captain Mike Fisher will serve as Grand Marshal for this year’s 64th annual Piedmont Natural Gas Nashville Christmas Parade presented by Tootsie’s Orchid Lounge. Children’s Hospital will again benefit from some of the proceeds from the parade. -
October 30, 2017
Emergency tabletop exercise scheduled for Nov. 7
Vanderbilt’s Office of Emergency Preparedness, Fire and Workplace Safety will host representatives from across the university who play a key role in disaster mitigation, preparedness, response and recovery for an emergency tabletop training exercise on Nov. 7. -
October 27, 2017
Impulsivity in Parkinson’s Disease
A noninvasive MRI technique may help predict a troubling side effect of common medications for Parkinson’s Disease and improve clinical treatment plans. -
October 26, 2017
Gut response to fluid flow
Vanderbilt researchers have discovered that microvilli – finger-like projections from cells in the intestine – respond to the shear stress of fluid flow to drive a cellular pathway that regulates nutrient balance. -
October 26, 2017
School of Nursing receives HRSA grant for Clinic at Mercury Courts mental health providers
The two-year Title VIII grant from the Health and Human Services Administration allows the Clinic at Mercury Courts, a nurse-managed primary care clinic located in one of Nashville’s most economically depressed areas, to add a psychiatric-mental health nurse practitioner, social worker and psychiatrist to its existing primary care team. -
October 26, 2017
Study to test combination therapy for breast cancer
Vanderbilt-Ingram Cancer Center (VICC) has received $2.3 million to fund a clinical research trial testing a combination of three immunotherapy compounds for patients with a specific type of advanced breast cancer.